HLTW:PA:PA-Multi Units Luxembourg - Lyxor MSCI World Health Care TR UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 496.6

Change

-0.59 (-0.12)%

Market Cap

USD 0.75B

Volume

470.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Sub-Fund is an index-tracking UCITS passively managed. The Reference Currency of the Sub-Fund is the Euro (EUR). The investment objective of sub-fund is to track both the upward and the downward evolution of the MSCI World Health Care Index " Net Total Return (the Index) denominated in US Dollars - while minimising the volatility of the difference between the return of the Sub-Fund and the return of the Index (the "Tracking Error"). The anticipated level of the tracking error under normal market conditions is expected to be up to 0.50%.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.81 (+1.76%)

USD 62.43B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.30 (-0.06%)

USD 12.61B
WRD:PA HSBC ETFs Public Limited Compa..

+0.08 (+0.25%)

USD 10.15B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+3.07 (+1.27%)

USD 8.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.30 (+0.07%)

USD 7.87B
HHH:PA HSBC ETFs Public Limited Compa..

-0.02 (-0.03%)

USD 7.00B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.80 (+0.24%)

USD 6.81B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.33%)

USD 6.39B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.40 (-0.11%)

USD 4.94B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.17 (-0.12%)

USD 4.74B

ETFs Containing HLTW:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.63% 56% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.63% 54% F 67% D+
Trailing 12 Months  
Capital Gain 13.22% 35% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.22% 34% F 55% F
Trailing 5 Years  
Capital Gain 67.13% 74% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.13% 73% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.83% 63% D 64% D
Dividend Return 9.83% 64% D 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.85% 66% D+ 84% B
Risk Adjusted Return 111.05% 99% N/A 96% N/A
Market Capitalization 0.75B 76% C+ 77% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike